Evidence map›Paper›PMID 34252412›Full record

ArticleToxicology and applied pharmacology2021

Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.

J J Schlezinger, T Hyötyläinen, T Sinioja, C Boston, H Puckett, J Oliver, W Heiger-Bernays, T F Webster

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

J J SchlezingerDepartment of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA. Electronic address: jschlezi@bu.edu.
T HyötyläinenMTM Research Centre, School of Science and Technology, Örebro University, Örebro 702 81, Sweden.
T SiniojaMTM Research Centre, School of Science and Technology, Örebro University, Örebro 702 81, Sweden.
C BostonDepartment of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.
H PuckettDepartment of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.
J OliverDepartment of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.
W Heiger-BernaysDepartment of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.
T F WebsterDepartment of Environmental Health, Boston University School of Public Health, Boston, MA 02118, USA.
Boston University · USÖrebro University · SE

Funding

Training CoreP42ES007381 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAHN, MARK E · 1995 to 2019
$46.1M
Novel Analytical and Experimental Approaches for Predicting the Biological Effects of MixturesR01ES027813 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WEBSTER, THOMAS F · 2017 to 2021
$2.2M
QUANTSTUDIO 12K FLEX OPEN ARRAY REAL-TIME PCR SYSTEMS10OD023663 · OD · BOSTON MEDICAL CENTER · PI DENG, LINGYI L · 2017 to 2017
$186k
NIEHS NIH HHS P42 ES007381NIEHS NIH HHS R01 ES027813NIH HHS S10 OD023663
6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS) are pervasive in the environment resulting in nearly universal detection in people. Human serum PFAS concentrations are strongly associated with increased serum low-density lipoprotein cholesterol (LDL-C), and growing evidence suggests an association with serum triacylglycerides (TG). Here, we tested the hypothesis that perfluorooctanoic acid (PFOA) dysregulates liver and serum triacylglycerides in human peroxisome proliferator activated receptor α (hPPARα)-expressing mice fed an American diet. Mice were exposed to PFOA (3.5 mg/L) in drinking water for 6 weeks resulting in a serum concentration of 48 ± 9 μg/ml. In male and female hPPARα mice, PFOA increased total liver TG and TG substituted with saturated and monounsaturated fatty acids. Lack of expression of PPARα alone also increased total liver TG, and PFOA treatment had little effect on liver TG in PPARα null mice. In hPPARα mice, PFOA neither significantly increased nor decreased serum TG; however, there was a modest increase in TG associated with very low-density cholesterol particles in both sexes. Intriguingly, in female PPARα null mice, PFOA significantly increased serum TG, with a similar trend in males. PFOA also modified fatty acid and TG homeostasis-related gene expression in liver, in a hPPARα-dependent manner, but not in adipose. The results of our study and others reveal the importance of context (serum concentration and genotype) in determining the effect of PFOA on lipid homeostasis.

Indexed as

Diet, WesternAnimalsBody WeightCaprylatesDyslipidemiasFemaleFluorocarbonsGene ExpressionGenotypeLipidomicsLiverMaleMice, TransgenicOrgan SizePPAR alphaTriglyceridesCaprylatesFluorocarbonsperfluorooctanoic acidPPAR alphaTriglyceridesLipid homeostasisPerfluorooctanoic acidPeroxisome proliferator activated receptor αTriacylglyceride

Identifiers

PMID34252412
PMCPMC8338894
OpenAlexW3178734264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.